Corporate Finace

Vator Securities provides an extensive range of capital markets and advisory services to cutting-edge public and private growth companies with an emphasis on the Life Sciences, Medical Technology and Diagnostics sectors.

Private Office

Private Office is Vator Securities’ unique investment concept for financial services and is offered only to the company's Core and BlackLine clients. The Private Office concept enables private investors an alternative that has previously been reserved only for institutions.

Klipp från EFNs Börslunch där Vator Securities VD Homan Panahi pratar om det svenska life science-undret och betydelsen för framväxten av nya framgångsrika life science-bolag i Sverige. Se programmet här.

Vator Securities advises Visiopharm on a DKK100 million private placement

24 August 2018

ATP, the Danish Growth Fund and the C. L. David Foundation and Collection are among the new investors. The increased capital commitment is an essential part of the company’s growth strategy within the field of tissue diagnostics- and research software for cancer.

Vator Securities Sole Bookrunner in Nanoform SEK 71 million private placement

5 July 2018

The private placement was directed to Swedish and Finnish, HNWI, family offices and institutional investors where Mandatum Life Insurance Company (Sampo Group) acted as anchor investor.

Vator Securities advises AlzeCure Pharma on SEK 40 million directed share issue

2 July 2018

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 40 million.

Sole Bookrunner in the largest ever direct share issue in a diagnostics company in Sweden

12 June 2018

Vator Securities Sole Bookrunner in successful SEK 324 million direct share issue in Immunovia, the largest ever in a diagnostics company in Sweden Immunovia´s core technology platform,…

More News